Cancer patients with high muscle strength and cardiorespiratory fitness (CRF) had a significantly lower risk of death from any cause, including those with advanced cancers, a large retrospective ...
Nearly half of patients with advanced ovarian cancer treated with first-line poly-ADP-ribose polymerase (PARP) inhibitors experienced recurrence in this real-world study, emphasizing the need for ...
The phase 3 CheckMate 649 trial showed that nivolumab plus chemotherapy significantly improved long-term overall survival in Chinese patients with advanced gastric, gastroesophageal junction, and ...